Feedback / Questions
ZKN-013 - Almirall
https://www.globenewswire.com/news-release/2024/03/13/2845650/0/en/Almirall-and-Eloxx-Pharmaceuticals-Enter-into-Exclusive-Agreement-to-license-ZKN-013-for-rare-dermatological-diseases.html
Mar 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next